New Ray Medic International Holdings Limited ("New Ray Medic") issued a supplementary announcement on July 16, 2024, providing further information on the annual report for the year ended December 31, 2023. The annual report shows that the company raised approximately HKD 330.0 million through share offering activities, of which approximately HKD 39.6 million has not been used. New Ray Medic pointed out that due to economic instability and the impact of the Covid-19 pandemic, the company remains cautious when looking for suitable business or investment opportunities. The company plans to use the unused income for business expansion in the domestic market in China and as general operating capital for the group. The announcement mentioned that about HKD 17.3 million has been allocated for the acquisition of 16% of the shares of China Nuwa Pharmaceutical Group Co., Ltd., and about HKD 22.3 million is planned to be used for general operations of the group. The board of directors includes Chairman and Executive Director Ms. Wang Qiuyin and others.

New Ray Medic International Holdings Limited ("New Ray Medic") issued a supplementary announcement on July 16, 2024, providing further information on the annual report for the year ended December 31, 2023. The annual report shows that the company raised approximately HKD 330.0 million through share offering activities, of which approximately HKD 39.6 million has not been used. New Ray Medic pointed out that due to economic instability and the impact of the Covid-19 pandemic, the company remains cautious when looking for suitable business or investment opportunities. The company plans to use the unused income for business expansion in the domestic market in China and as general operating capital for the group. The announcement mentioned that about HKD 17.3 million has been allocated for the acquisition of 16% of the shares of China Nuwa Pharmaceutical Group Co., Ltd., and about HKD 22.3 million is planned to be used for general operations of the group. The board of directors includes Chairman and Executive Director Ms. Wang Qiuyin and others.